Enterprise Innovation brings internal and external collaboration opportunities to our faculty and trainees. These programs provide extra funding and opportunities to work with industry to advance faculty/trainees' translational research projects.
Please contact Dr. James Bellush at james.bellush@cornell.edu if you have any questions or need guidance on your application.
1. Alkermes: Investigator Sponsored Study Cycle
- Eligibility: Alkermes’ Independent Sponsored Studies (ISS) program is designed to support independent clinicians focusing on: interventional, observational, registry, meta-analysis, and patient reported outcomes research
- Substance Use Disorder
- Treatment initiation and adherence (AUD/OUD)
- Treatment outcomes and real world data (AUD/OUD)
- Neurologic profile of early recovery, including sleep, cognition, craving
- Digital technologies for physiological monitoring, (e.g. wearables)
- Schizophrenia
- Benefits and outcomes of long-acting injectables (LAI) in schizophrenia subpopulations, comorbidities
- Economic and clinical outcomes of LAI treatment using real world data
- Submission Details: Full application guidelines and documentation here
- Award Details: Up to $300,000 (funding term variable)
- Submission Deadline: April 30, 2025
2. American Society of Hematology: ASH Bridge Grant Program
- Eligibility: ASH Bridge Grant program is intended to help sustain hematology research and member retention in the face of severe funding reductions for the NIH. Eligible applicants will be tenure track faculty with ASH membership who have applied for an NIH R01 grant or equivalent (R23, R29, R37) in the past 18 months.
- Submission Details: Please see required materials here:
- Bridge Grant application, budget supplemental form, NIH biosketch, institutional commitment letter.
- Award Details: $150k for one-year (used for PI salary + fringe, travel, personnel, or research equipment / supplies.
Submission Deadline: May 1, 2025
3. American Heart Association: Pilot Grants for AHA Protein Binding Atlas
- Eligibility: AHA is soliciting applications for innovative pilot projects aimed at predicting and understanding protein-protein / protein-small molecule interactions involved in key biological processes associated with cardiovascular, kidney, and metabolic diseases, including obesity. Proposed projects are encouraged to utilize the AHA Protein Portal for computational modeling, proteomics, network biology, and systems biology to deliver predictive insights for therapeutics development.
- Submission Details: Applications must be submitted using ProposalCentral
- Award Details: $100k for one year
Submission Deadline: May 1, 2025
4. Association for Frontotemporal Degeneration: FTD Biomarkers Initiative
Eligibility: Provides funding for researchers seeking to advance the understanding and clinical utilization of comprehensive FTD biomarkers. Specific focus on developing tools for neurology and specialty clinics that will simplify, accelerate, and improve accuracy of FTD diagnosis.
- Focus on proposals which will enhance: patient screening / stratification, diagnostic accuracy, and subtyping of pathophysiology to inform critical care
- Submission Details: Detailed grant application instructions can be found at RFP website. All application materials must be submitted through AFTD portal.
- Award Details: $250,000 – $700,000 for two years (dependent upon development stage and project scope)
- Submission Deadline: May 9, 2025
5. Citizens United for Research in Epilepsy (CURE): Catalyst Award
Eligibility: Independent researchers seeking funding to accelerate discovery / development of transformative therapies in epilepsy. Award is designed to support acquisition of data necessary to attract larger commercial funding opportunities for translational therapy.
- Submission Details: Portal opens on Tuesday, May 13. Please find relevant application information here.
- Award Details: $250,000 – $250,000 for two years
- Submission Deadline: June 10, 2025